Biblio
Decoding the historical tale: COVID-19 impact on haematological malignancy patients-EPICOVIDEHA insights from 2020 to 2022. EClinicalMedicine. 2024;71:102553.
ECP versus ruxolitinib in steroid-refractory acute GVHD - a retrospective study by the EBMT transplant complications working party. Front Immunol. 2023;14:1283034.
ECP versus ruxolitinib in steroid-refractory chronic GVHD - a retrospective study by the EBMT transplant complications working party. Bone Marrow Transplant. 2024.
Editorial: 50 years of BMT: long-term outcomes and late complications after transplantation. Front Oncol. 2023;13:1253971.
. Hemoglobinopathies and COVID-19: The Experience of a Center in Northern Greece. Hemoglobin. 2022:1-3.
.